Kleiner Perkins Caufield & Byers XV, LLC
CIK 1547840 · last filed 2020-10-20
Kleiner Perkins Caufield & Byers XV, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for RAPT, was dated Oct 20, 2020. Current disclosed insider exposure totals $25.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.4K
2
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) Delisted | 10%+ Owner | 243,383 | $58.01 | $14.12M | $0 | 2 | 2020-10-20 |
| ATRA | 10%+ Owner | 3,105 | $8.17 | $25.4K | $0 | 1 | 2014-10-23 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-20 | RAPT Therapeutics, Inc. (RAPT) Delisted | Other (J) | −1,950,000 | $0 | EDGAR |
| 2020-07-16 | RAPT Therapeutics, Inc. (RAPT) Delisted | Other (J) | −900,000 | $0 | EDGAR |
| 2014-10-23 | ATRA | Conv (C) | +5,722,260 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.